← Evidence map

ArticleMolecular oncology2009

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530.

Tim P Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

124 papers cite itlatest 60 shown

2009
…
2011
2012
2014
2015
2016
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT02737202phase 228 enrolled2016
Full record →Abstract, authors, funding and every citing paper · PMID 19393585